How Innovative Therapies are Driving the US Lung Cancer Market Forward
The U.S. lung cancer market is poised for transformative growth, with projections indicating a market size of approximately $18 billion by 2035. This significant expansion reflects a compound annual growth rate (CAGR) of 7.65%, highlighting the increasing attention and resources directed toward lung cancer treatment. Innovative therapies, particularly in immunotherapy and targeted therapies,...
0 Kommentare 0 Geteilt 6 Ansichten 0 Bewertungen